Search
  • LARISSA

On the 14th of November the WHO reported an outbreak of Rift Valley Fever (RVF) among both humans and livestock in the Republic of Sudan. The outbreak follows heavy rains and flash flooding in August that affected nearly all of the country.


From 19 September 2019 until 11 November 2019, a total of 293 suspected human RVF cases, including 11 associated deaths have been reported from six states; including the Red Sea (120), River Nile (168), Kassala (2), White Nile (1), Khartoum (1), and Al Qadarif (1) States. The most affected age group is 15-45 years old, which accounts for 83% of the total suspected cases. The male to female ratio is 2.6, with a high proportion of the cases being farmers (37.5%).


These human RVF cases are concomitant with abortions and deaths among goats in the areas where the human suspected and confirmed cases have been reported. From 25 September through 3 November 2019, 21 goats in Red Sea State were reported as positive for RVF, including 4 deaths; and in River Nile State 16 goats, with 3 deaths, and 37 sheep, with 5 deaths, were confirmed positive for RVF by ELISA test at the Central Veterinary Research Laboratory in Khartoum.



Read more on https://www.who.int/csr/don/14-november-2019-rift-valley-fever-republic-of-the-sudan/en/

In the LARISSA project, six consortium partners work with CEPI to develop and validate a novel vaccine against Rift Valley Fever. It is the first vaccine that potentially provides full protection with a single dose and has an optimal safety profile. 

Subscribe to Our Newsletter

CONTACT >

E: info@bunyavax.com

© 2019 by BunyaVax BV.